Cargando…

Effects of Sex and Seasonal Climatic Changes on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study

Background and Objectives: Seasonal climatic changes may affect the development of the rash that is characteristic of treatment with anti-epidermal growth factor receptor (EGFR) antibodies. We evaluated the association between seasons and rash incidence among patients with cancer. Materials and Meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arai, Takahiro, Fujita, Yukiyoshi, Imai, Hisao, Matsumoto, Hiroe, Yamazaki, Miho, Hiruta, Eriko, Suzuki, Yuka, Ojima, Hitoshi, Hosaka, Hisashi, Minato, Koichi, Saito, Taeko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401647/ https://www.ncbi.nlm.nih.gov/pubmed/34441007 http://dx.doi.org/10.3390/medicina57080801

Ejemplares similares

A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer
por: Kamiya, Teruhiko, et al.
Publicado: (2023)

A retrospective study of the efficacy and safety of naldemedine for opioid‐induced constipation in thoracic cancer patients
por: Imai, Hisao, et al.
Publicado: (2022)

Efficacy and Safety of Naldemedine for Patients with Cancer with Opioid-Induced Constipation in Clinical Practice: A Real-World Retrospective Study
por: Nishiba, Hiromi, et al.
Publicado: (2022)

Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study
por: Hiruta, Eriko, et al.
Publicado: (2021)

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations
por: Yamada, Yutaka, et al.
Publicado: (2021)

Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing EGFR Mutations
por: Imai, Hisao, et al.
Publicado: (2021)

Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors
por: Nakahara, Takeshi, et al.
Publicado: (2015)

Low‐Dose Olanzapine Plus Granisetron and Dexamethasone for Carboplatin‐Induced Nausea and Vomiting in Patients with Thoracic Malignancies: A Prospective Multicenter Phase II Trial
por: Sakai, Chizuru, et al.
Publicado: (2021)

Clinical significance of post‐progression survival in lung cancer
por: Imai, Hisao, et al.
Publicado: (2017)

Post‐progression survival is highly linked to overall survival in patients with non‐small‐cell lung cancer harboring sensitive EGFR mutations treated with first‐line epidermal growth factor receptor‐tyrosine kinase inhibitors
por: Imai, Hisao, et al.
Publicado: (2019)

Management of Lung Cancer-Associated Malignant Pericardial Effusion with Intrapericardial Administration of Carboplatin: A Retrospective Study
por: Imai, Hisao, et al.
Publicado: (2021)

Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
por: Hichert, Vivien, et al.
Publicado: (2017)

Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients
por: Gerber, Peter Arne, et al.
Publicado: (2012)

Intrapericardial carboplatin in the management of malignant pericardial effusion in breast cancer: a pilot study
por: Kotake, Mie, et al.
Publicado: (2019)

Conversion surgery for metastatic gastric cancer at 2 years after initial diagnosis of cancer of unknown primary with metastasis of cervical lymph nodes and ovary: a case report
por: Suzuki, Masaki, et al.
Publicado: (2021)

Updated Analysis of NEJ009: Gefitinib-Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated EGFR
por: Miyauchi, Eisaku, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies
por: Ohashi, Takashi, et al.
Publicado: (2022)

Clinical Significance of the Relationship between Progression-Free Survival or Postprogression Survival and Overall Survival in Patients with Extensive Disease-Small-Cell Lung Cancer Treated with Carboplatin plus Etoposide
por: Imai, Hisao, et al.
Publicado: (2016)

Enema Rashes
Publicado: (1902)

Bromide Rashes
Publicado: (1907)

Vaccination Rashes
Publicado: (1908)

An Antimony Rash
por: Kundu, Sarat Sasi
Publicado: (1925)

Antipsychotics and rashes
por: Lin, Jessica
Publicado: (2018)

Veronal Rashes
Publicado: (1908)

The Whiplash Rash
por: Brahmnalkar, Ajay M., et al.
Publicado: (2017)

Quinine Rash
por: Nunn, R. J.
Publicado: (1879)

Measles Rash
Publicado: (1916)

Butterfly Rash
por: Chakraborty, Sayantani, et al.
Publicado: (2022)

Woman with rash
por: Kelly, Geoffrey S., et al.
Publicado: (2022)

Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice
por: Takanashi, Seiji, et al.
Publicado: (2012)

Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
por: Melosky, B., et al.
Publicado: (2009)

Reducing Acneiform Rash Induced by EGFR Inhibitors With Honeysuckle Therapy: A Prospective, Randomized, Controlled Study
por: Liu, Zhen, et al.
Publicado: (2022)

Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer
por: Yamazaki, Motohiko, et al.
Publicado: (2022)

CORRIGENDUM: Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice
por: Takanashi, Seiji, et al.
Publicado: (2013)

Clinical impact of post‐progression survival on overall survival in elderly patients with extensive disease small‐cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2016)

Course of postoperative relapse in non‐small cell lung cancer is strongly associated with post‐progression survival
por: Imai, Hisao, et al.
Publicado: (2021)

Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib
por: Yamaguchi, Ou, et al.
Publicado: (2023)

A Desert Rash
por: Bledsoe, Bryan E, et al.
Publicado: (2011)

What is the diagnosis for this rash?
por: Singh, Namrata, et al.
Publicado: (2013)

Bullous Iodide Rash
Publicado: (1909)

Cannot write session to /tmp/vufind_sessions/sess_4m205l2ekbui2ddfmu5tvvla31